Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T51426 | Target Info | |||
Target Name | Farnesoid X-activated receptor (FXR) | ||||
Synonyms | Retinoid X receptor-interacting protein 14; RXR-interacting protein 14; RIP14; Nuclear receptor subfamily 1 group H member 4; HRR1; Farnesol receptor HRR-1; FXR; Bile acid receptor; BAR | ||||
Target Type | Successful Target | ||||
Gene Name | NR1H4 | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 2-[(1R,5S)-9-[[3-[2,6-bis(chloranyl)phenyl]-5-cyclopropyl-1,2-oxazol-4-yl]methoxy]-3-azabicyclo[3.3.1]nonan-3-yl]-1,3-benzothiazole-6-carboxylic acid | Ligand Info | |||
Canonical SMILES | C1CC2CN(CC(C1)C2OCC3=C(ON=C3C4=C(C=CC=C4Cl)Cl)C5CC5)C6=NC7=C(S6)C=C(C=C7)C(=O)O | ||||
InChI | 1S/C29H27Cl2N3O4S/c30-20-5-2-6-21(31)24(20)25-19(27(38-33-25)15-7-8-15)14-37-26-17-3-1-4-18(26)13-34(12-17)29-32-22-10-9-16(28(35)36)11-23(22)39-29/h2,5-6,9-11,15,17-18,26H,1,3-4,7-8,12-14H2,(H,35,36)/t17-,18+,26? | ||||
InChIKey | LRGRHLPTAIKGDV-PQJFKPCWSA-N | ||||
PubChem Compound ID | 134817776 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6A5X FXR-LBD with HNC180 and SRC1 | ||||||
Method | X-ray diffraction | Resolution | 2.60 Å | Mutation | Yes | [1] |
PDB Sequence |
ELTPDQQTLL
253 HFIMDSYNKQ263 RMPQEITNKI273 LKEEFSAEEN283 FLILTEMATN293 HVQVLVEFTK 303 KLPGFQTLDH313 EDQIALLKGS323 AVEAMFLRSA333 EIFNKKLPSG343 HSDLLEERIR 353 NSGISDEYIT363 PMFSFYKSIG373 ELKMTQEEYA383 LLTAIVILSP393 DRQYIKDREA 403 VEKLQEPLLD413 VLQKLCKIHQ423 PENPQHFAEL433 LGRLTELRTF443 NHHHAEMLMS 453 WRVNDHKFTP463 LLEEIWDVQ
|
|||||
|
GLN263
4.995
ARG264
3.454
MET265
3.914
THR270
3.599
ILE273
3.996
PHE284
3.759
LEU287
3.700
THR288
3.436
MET290
3.847
ALA291
3.858
HIS294
3.772
VAL325
4.782
MET328
3.488
PHE329
3.248
ARG331
3.028
SER332
3.639
|
|||||
PDB ID: 6A5Z Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1 | ||||||
Method | X-ray diffraction | Resolution | 2.95 Å | Mutation | Yes | [1] |
PDB Sequence |
ELTPDQQTLL
253 HFIMDSYNKQ263 RMPQEITNKI273 LKEEFSAEEN283 FLILTEMATN293 HVQVLVEFTK 303 KLPGFQTLDH313 EDQIALLKGS323 AVEAMFLRSA333 EIFNKSDLLE349 ERIRNSGISD 359 EYITPMFSFY369 KSIGELKMTQ379 EEYALLTAIV389 ILSPDRQYIK399 DREAVEKLQE 409 PLLDVLQKLC419 KIHQPENPQH429 FAELLGRLTE439 LRTFNHHHAE449 MLMSWRVNKF 461 TPLLEEIWDV471
|
|||||
|
GLN263
4.685
ARG264
4.734
MET265
3.733
THR270
4.779
PHE284
3.911
LEU287
4.035
THR288
3.796
MET290
3.258
ALA291
3.963
HIS294
3.989
VAL325
4.530
MET328
3.096
PHE329
3.235
ARG331
2.550
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Ligand binding and heterodimerization with retinoid X receptor Alpha (RXRAlpha) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding. J Biol Chem. 2018 Nov 23;293(47):18180-18191. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.